Seeking Alpha

More on Boston Scientific (BSX -2.5%) Q3: swings to net loss of $725M from a net profit of $142M...

More on Boston Scientific (BSX -2.5%) Q3: swings to net loss of $725M from a net profit of $142M a year ago, with the latest results including charges of $946M. Expects Q4 adjusted EPS of $0.15-$0.18 on sales of $1.74B-$1.815B vs. consensus of $0.12 and $1.8B respectively. Narrows FY forecasts to EPS of $0.63-$0.66 on revenue of $7.17B-$7.24B vs. $0.42 and $7.26B.

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs